Eugene

[email protected]

LATEST

Takeda Issues US Recall of Thyroid Drug Natpara Due to Particulates from Cartridge
By

By
Takeda Pharmaceutical has issued a US recall for all doses of Natpara (parathyroid hormone), a thyroid treatment, for injection (25 mcg, 50, mcg, 75 mcg, and 100 mcg) after discussions…

JHL Biotech Settles with Genentech in Intellectual Property Litigation
By

By
JHL Biotech, a contract development and manufacturing organization (CDMO) and developer of biosimilars, has reached a settlement agreement with Roche’s Genentech to resolve Genentech’s civil claims related to the indictment…

Mallinckrodt Agrees to Sell CDMO BioVectra to PE Firm HIG Capital for $250 Million
By

By
Mallinckrodt has agreed to sell its wholly owned subsidiary, BioVectra, a contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and intermediates, to an affiliate of HIG Capital,…

Mallinckrodt Reaches $30-Million Settlement in Principle in Opioid Litigation
By

By
Mallinckrodt, along with its wholly owned subsidiaries, Mallinckrodt LLC and SpecGx LLC, has reached a $30-million settlement in principle with two Ohio counties in pending opioid litigation. Mallinckrodt reached the…

Sumitomo Dainippon Pharma, Roivant Sciences Announce Plans for $3-Billion Alliance
By

By
Sumitomo Dainippon Pharma, and Roivant Sciences, a New York-based healthcare company, have entered into a non-binding memorandum of understanding for a broad alliance to transfer ownership interests in five Roivant…

Vertex To Acquire Semma Therapeutics for $950 Million
By

By
Vertex Pharmaceuticals has agreed to acquire Semma Therapeutics, a privately held biotechnology company specializing in Type 1 diabetes treatments, for $950 million in cash. Semma has developed a therapeutic approach…

Biocon Receives CRL from FDA for Mfg Issues for Biosimilar of Sanofi’s Lantus
By

By
The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) over manufacturing issues for a new drug application filed by Biocon and Mylan for a biosimilar…

Lonza, Chr. Hansen Form New Bio JV BacThera With $99-Million Investment
By

By
Lonza and Chr. Hansen Holding, a bioscience company, have received approval from antitrust regulators needed to establish a 50/50 joint venture in the live biotherapeutic product market. The companies, which…

Lonza, Celltrion Partner; SK To Launch US-HQ API Ops; Catalent To Expand
By

By
The latest news from CDMOs, CMOs, and suppliers, featuring news from SK, Lonza, Catalent, and Velesco Pharma. Chemicals/Chemical API Manufacturing SK Holdings To Launch CDMO Business With New Identity in…

Allergan Announces $5.0-Million Settlement with Two Ohio Counties in Opioid Litigation
By

By
Allergan and its US subsidiaries have reached a $5.0-million settlement with Summit and Cuyahoga Counties in Ohio relating to pending opioid litigation. The company was scheduled for a trial in…